The role of Mindfulness-Based Cognitive Therapy in reducing rumination in recurrent depression: the effect on attention and emotion regulation functions

niversity of Bergen0 个研究点目标入组 68 人开始时间: 2018年11月22日最近更新: 2024年2月19日

适应症

试验速览

2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32503649/ results (added 08/06/2020) 2019 Other publications in https://pubmed.ncbi.nlm.nih.gov/31695636/ (added 03/01/2023) 2022 Other publications in https://pubmed.ncbi.nlm.nih.gov/35330721/ (added 03/01/2023) 2024 Other publications in https://pubmed.ncbi.nlm.nih.gov/38312915/ Secondary analyses (added 05/02/2024)

•Clinical group:
•1. Age: 18 - 70 years old
•2. Both genders
•3. At least three previous depressive episodes, and to currently fulfill the diagnostic criteria for recurrent depression, and in full/partial remission from depression
•4. Patients may continue on antidepressant while participating in the study. It is, however, important that they do not discontinue or change dosage of medication while receiving the interventions of MBCT
•5. No current neurological, cardiac or hormonal diseases
•6. Borderline Personality Disorder (as assessed by SCID-II)
•Healthy control group:
•1. Age: 18-70 years old
•2. No current or prior psychiatric illness (as indicated by M.I.N.I.)
•3. No current neurological, cardiac or hormonal diseases

•1. Acute suicidal danger, a lifetime history of psychosis/schizophrenia, bipolar disorder, substance use disorders
•2. Ongoing or mindfulness based treatment past 2 years
•3. Ongoing psychotherapy
•4. Pregnant/lactating

发起方

niversity of Bergen